These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 18043973)
1. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Logan-Collins JM; Lowy AM; Robinson-Smith TM; Kumar S; Sussman JJ; James LE; Ahmad SA Ann Surg Oncol; 2008 Mar; 15(3):738-44. PubMed ID: 18043973 [TBL] [Abstract][Full Text] [Related]
2. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. Bijelic L; Yan TD; Sugarbaker PH J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival. Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231 [TBL] [Abstract][Full Text] [Related]
6. Appendiceal cancer and peritoneal carcinomatosis: a report of 29 cases. Esquivel J; Merriman B; Davis S; Manning D Am Surg; 2006 Aug; 72(8):714-7; discussion 717-8. PubMed ID: 16913315 [TBL] [Abstract][Full Text] [Related]
7. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Yan TD; Bijelic L; Sugarbaker PH Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772 [TBL] [Abstract][Full Text] [Related]
8. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929 [TBL] [Abstract][Full Text] [Related]
9. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363 [TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei]. Lu YY; Guo AT; Liu AJ; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925 [TBL] [Abstract][Full Text] [Related]
12. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Mahteme H; Sugarbaker PH Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269 [TBL] [Abstract][Full Text] [Related]
13. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma. Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153 [TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Bruin SC; Verwaal VJ; Vincent A; van't Veer LJ; van Velthuysen ML Ann Surg Oncol; 2010 Sep; 17(9):2330-40. PubMed ID: 20232161 [TBL] [Abstract][Full Text] [Related]
17. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination. Huang Y; Alzahrani NA; Chua TC; Morris DL Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002 [TBL] [Abstract][Full Text] [Related]
18. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma. Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Halabi HE; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A Ann Surg Oncol; 2012 Jan; 19(1):122-5. PubMed ID: 21748246 [TBL] [Abstract][Full Text] [Related]
20. Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation? Zih FS; Wong-Chong N; Hummel C; Petronis J; Panzarella T; Pollett A; McCart JA; Swallow CJ Ann Surg Oncol; 2014 Jan; 21(1):225-31. PubMed ID: 24100959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]